Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Not Yet Recruiting

Sonrotoclax, Zanubrutinib and Rituximab in Previously Untreated Patients With Follicular Lymphoma

NCT07550855

Conditions: Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Sun Yat-sen Universitiy Cancer Center Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma

NCT07542912

Conditions: Adverse Event, Complete Remission Rate， CRR, Duration of Response, +8 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, China

View Trial Details

Not Yet Recruiting

Phase I Clinical Study on the Safety and Efficacy of CY-219 CAR-T Cell Injection in the Treatment of Relapsed/Refractory B-Cell Lymphoma

NCT07539688

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Epidemiology and Management of Cutaneous T-Cell Lymphoma at Hospital México, Costa Rica.

NCT07538960

Conditions: Cutaneous, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Hospital México San José, Uruca, Costa Rica

View Trial Details

Not Yet Recruiting

Evaluation of the Safety and Efficacy of Sup19 CAR-T Cells in Patients With Previously Failed CD19-Targeted Therapy or CD19-Weakly Expressed Hematologic Tumors

NCT07539610

Conditions: B Acute Lymphoblastic Leukemia/Lymphoma, B-Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +16 more
Locations: Institute of Hematology, Chinese Academy of Medical Sciences & Hospital of Hematology, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China

View Trial Details

Not Yet Recruiting

Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma

NCT07535710

Conditions: Cutaneous T Cell Lymphoma (CTCL), Cutaneous T-Cell Lymphoma Refractory, Cutaneous T-Cell Lymphoma, Relapsed, +16 more
Locations: Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Shanghai, China

Ruijin Hospital Wuxi Branch Wuxi, China

View Trial Details

Not Yet Recruiting

Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma

NCT07535762

Conditions: Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative), Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Shanghai, China

Ruijin Hospital Wuxi Branch Wuxi, China

View Trial Details

Not Yet Recruiting

Geriatric-guided Care Versus Conventional Care in Elderly Unfit/Frail Patients With Diffuse Large B-cell Lymphoma in First Line Treatment

NCT07476105

Conditions: Diffuse Large B Cell Lymphoma, Follicular Lymphoma Grade 3B, Hemic and Lymphatic Diseases, +10 more
Locations: Azienda Ospedaliero Universitaria delle Marche - S.O.D. Clinica Ematologica Ancona, Italy

A.O.R.N. S. Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico Avellino, Italy

I.R.C.C.S. Centro di Riferimento Oncologico - S.O.C. Oncologia medica e dei tumori immuno-correlati Aviano, Italy

I.R.C.C.S. Istituto Tumori Giovanni Paolo II - U.O.C. Ematologia Bari, Italy

View all 24 locations

View Trial Details

Not Yet Recruiting

A Study of VG712 in Patients With Mycosis Fungoides

NCT07529405

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Not Yet Recruiting

Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

NCT07520006

Conditions: B-cell Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +19 more
Locations: Not specified

View Trial Details

Lymphoma, Non-Hodgkin

Lymphoma, Non-Hodgkin trial results

Related conditions